No Data
These 4 Measures Indicate That Boai NKY Medical Holdings (SZSE:300109) Is Using Debt Reasonably Well
Boai NKY Medical: Last year's Net income decreased by about 30% year-on-year, the proportion of Medical Services Business fell below 10% | Interpretations
① The gross margin of the PVP series products is under pressure, and the company's revenue will increase while profits decrease in 2024; ② The Medical Services business now accounts for less than 10% of the company's performance.
NEW OPEN SOURCE: 2025 FIRST QUARTER REPORT
New Open Source: 2024 Annual Report Summary
NEW OPEN SOURCE: 2024 ANNUAL REPORT
Boai NKY Medical (300109.SZ): In the first quarter, the Net income was 80.4203 million yuan, a year-on-year decrease of 33.75%.
On April 18, Gelonghui reported that Boai NKY Medical (300109.SZ) announced its first-quarter report for 2025, achieving a revenue of 0.325 billion yuan in the first quarter, a year-on-year decrease of 17.69%; the Net income attributable to the shareholders of the listed company was 80.4203 million yuan, a year-on-year decrease of 33.75%; the Net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 69.4162 million yuan, a year-on-year decrease of 44.85%; and the EPS was 0.17 yuan.